MelliCell Company
MelliCell develops therapeutics for diabetes and obesity using proprietary technologies that model weight gain in human fat cells in vitro. Founded in 2020, the company is headquartered in Newton, Massachusetts.
Industry:
Regenerative Medicine
Headquarters:
Newton, Massachusetts, United States
Zip:
1-10
Founded Date:
2020-01-01
Employees Number:
1-10
Investors Number:
2899555
Total Funding:
2899555
Last Funding Date:
Venture - Series Unknown
Last Funding Type:
info@mellicell.com
Register and Claim Ownership